Drug Interactions of Lipid-Altering Drugs
- 1 January 1998
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drug Safety
- Vol. 19 (5), 355-371
- https://doi.org/10.2165/00002018-199819050-00003
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- Combination of Pravastatin and Cyclosporin in Transplant PatientsClinical Pharmacokinetics, 1997
- EVALUATION OF FLUVASTATIN IN THE TREATMENT OF HYPERCHOLESTEROLEMIA IN RENAL TRANSPLANT RECIPIENTS TAKING CYCLOSPORINE1Transplantation, 1996
- Antihyperlipidaemic AgentsDrug Safety, 1994
- Comparison of effects of probucol versus vitamin E on ex vivo oxidation susceptibility of lipoproteins in hyperlipoproteinemiaThe American Journal of Cardiology, 1994
- Comparative efficacy and safety of pravastatin, nicotinic acid and the two combined in patients with hypercholesterolemiaThe American Journal of Cardiology, 1994
- Gemfibrozil-lovastatin-associated myalgiaThe American Journal of Cardiology, 1993
- Comparative Pharmacokinetics of Lovastatin, Simvastatin and Pravastatin in HumansThe Journal of Clinical Pharmacology, 1992
- The Bleeding Time Effects of a Single Dose of Aspirin in Subjects Receiving Omega‐3 Fatty Acid Dietary SupplementationThe Journal of Clinical Pharmacology, 1991
- Clinical experience with lovastatinThe American Journal of Cardiology, 1990
- Myolysis and Acute Renal Failure in a Heart-Transplant Recipient Receiving LovastatinNew England Journal of Medicine, 1988